Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

NorthStar Gaming Announces Revocation of Management Cease Trade...

May 21, 2025

3 Best-performing Canadian Cleantech Stocks of 2025

July 18, 2025

Casablanca Geophysics Highlights Antimony Targets at Depth

September 9, 2025

US Slaps 93.5 Percent Tariff on Chinese Graphite

July 21, 2025

Rio Silver to Complete 5:1 Consolidation

June 28, 2025

CDX May Investor Presentation

May 30, 2025

Earthwise Minerals Completes Phase 1 Field Program at...

August 26, 2025

China’s Mineral Export Ban Reinforces Electric Royalties’ Long-Term...

May 14, 2025

Kobo Resources: Unlocking West Africa’s Untapped Gold Potential

August 19, 2025

Drilling recommences at Yunndaga

July 10, 2025